| |
| |
|
| Insider
Information: |
Huang Jane |
| Relationship: |
|
| City: |
Camana Bay, Grand Cayman |
| State: |
E9 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
211,342 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$26,389,868 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
211,342 |
|
|
| Total
Value |
$26,389,868 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -163.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Beigene Ltd |
BGNE |
CMO, Hematology |
2021-12-14 |
160,055 |
2017-12-04 |
0 |
Premium* |
|
|
Prelude Therapeutics Inc |
PRLD |
|
2024-04-04 |
51,287 |
2023-04-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
110 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-03-07 |
4 |
AS |
$140.50 |
$9,976 |
D/D |
(71) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-09-04 |
4 |
AS |
$129.40 |
$10,611 |
D/D |
(82) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-05-20 |
4 |
AS |
$130.12 |
$39,036 |
D/D |
(300) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-05-20 |
4 |
OE |
$45.31 |
$13,593 |
D/D |
300 |
300 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-06-28 |
4 |
AS |
$365.00 |
$155,125 |
D/D |
(425) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-06-27 |
4 |
AS |
$124.50 |
$53,542 |
D/D |
(430) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-06-18 |
4 |
S |
$325.66 |
$152,733 |
D/D |
(469) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
540 |
540 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-06-01 |
4 |
AS |
$362.64 |
$195,828 |
D/D |
(540) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
542 |
542 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-09-01 |
4 |
S |
$310.53 |
$168,307 |
D/D |
(542) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
545 |
545 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-09-02 |
4 |
S |
$327.18 |
$178,314 |
D/D |
(545) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2017-11-16 |
4 |
AS |
$85.00 |
$51,000 |
I/I |
(600) |
2,100 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-06-07 |
4 |
S |
$351.55 |
$211,986 |
D/D |
(603) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2020-06-08 |
4 |
S |
$170.84 |
$107,800 |
D/D |
(631) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2017-11-20 |
4 |
AS |
$87.00 |
$87,000 |
I/I |
(1,000) |
1,100 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2017-12-21 |
4 |
OE |
$29.51 |
$29,510 |
D/D |
1,000 |
1,000 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2017-12-21 |
4 |
S |
$98.00 |
$98,000 |
D/D |
(1,000) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,049 |
1,049 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2021-12-01 |
4 |
S |
$357.32 |
$377,493 |
D/D |
(1,049) |
0 |
0 |
% |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2017-12-04 |
4 |
AS |
$86.00 |
$94,600 |
I/I |
(1,100) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2017-12-13 |
4 |
OE |
$29.51 |
$44,265 |
D/D |
1,500 |
1,500 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2017-12-13 |
4 |
S |
$94.21 |
$141,381 |
D/D |
(1,500) |
0 |
0 |
- |
|
| BGNE |
Beigene Ltd |
CMO, Hematology |
• – – |
2019-11-18 |
4 |
OE |
$29.49 |
$44,235 |
D/D |
1,500 |
1,500 |
0 |
- |
|
110 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
